脑部放疗，上午比下午敏感许多！
% D- g+ A6 Y3 G5 _" q! d
0 h. y a2 w* g- }
* |/ ?+ k- A- |Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.& [( Y$ }2 I7 a" g2 v+ _
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment? c, S) M. ]- T& T
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
5 ~1 b) x3 d% h# JSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
3 ]0 X/ I! v: |3 @8 |6 {( s- k- r
2 R9 |# P0 K0 P* u- P7 Y, q& Z0 @9 @9 y& zAbstract. ~( V, m3 W4 e- [7 }+ H
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.5 I! T& X9 o. a# G) b( `0 _
# E9 S, I( a1 h7 D8 L) U0 f9 RMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
+ l, U! o; X, B. E6 ^. V/ a, P2 z/ _! D A$ V1 h* u' ~$ u
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
" d t3 n$ o0 \5 T0 V9 b! x0 l
* u B1 L6 n' QCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
\! k# }% ^" a; n% }; A2 @
% Q$ q' Q" _' W1 t" F5 z- F |
脑膜转移诊疗潘振宇教授科普总结
脑膜转移诊疗潘振宇教授科普总结
脑膜转移 中位治疗生存期 3-6月
脑膜转移的临床表现
肺腺癌egfr19+骨转移，这样治疗可以
病情与治疗过程概述
患者年龄58岁，男性，已戒烟30年
1. 确诊情况（2025.05.26）：患
肿瘤患者出现水肿，11种缓解方法请收
作者：闵水肿是中晚期肺癌患者比较常见的一种副作用，它不仅影响美观，还给不少病友的
卡度联合安罗，谁让肿瘤缩小了
肺低分化腺，伴肉瘤样。卡度尼利单抗联合安罗替尼。两个疗程复查显示肿瘤缩小，胸膜增
父亲确诊“癌王”生命危在旦夕，医护
讲述者：吉吉整理者：pear
一年前，父亲被确诊为胰腺癌伴肝转移，那一刻，我的人生仿
/ K3 ?" f+ g# G. H6 Q7 ^
显身卡
